{"id":10299,"date":"2026-09-09T13:10:09","date_gmt":"2026-09-09T13:10:09","guid":{"rendered":"https:\/\/europepharmacy.eu\/?post_type=product&p=10299"},"modified":"2026-09-09T13:14:01","modified_gmt":"2026-09-09T13:14:01","slug":"sermorelin-dosage","status":"publish","type":"product","link":"https:\/\/europepharmacy.eu\/de\/shop\/sermorelin-dosage\/","title":{"rendered":"Sermorelin Dosage"},"content":{"rendered":"

Sermorelin Dosage<\/a><\/h1>\n
\n

Sermorelin<\/a> is a synthetic peptide analog of growth hormone-releasing hormone (GHRH), used to stimulate the pituitary gland to produce and release human growth hormone (hGH). It’s FDA-approved for diagnosing and treating growth hormone deficiency in children, but it’s also prescribed off-label for adults seeking anti-aging, muscle growth, or recovery benefits.\u00a0Important: This is general information only. Sermorelin is a prescription medication. Always consult a licensed healthcare provider for personalized dosing, as improper use can lead to side effects like injection site reactions, headaches, or hormonal imbalances. Self-administration without medical supervision is not recommended.<\/strong><\/p>\n

Standard Dosage Guidelines<\/h3>\n

Dosing varies by age, weight, condition, medical history, and lab results (e.g., IGF-1 levels). It’s typically administered via subcutaneous injection (under the skin) once daily, often at bedtime to mimic natural hGH pulses.<\/p>\n<\/div>\n

\n\n\n\n\n\n\n\n
Patient Group<\/th>\nTypical Dosage<\/th>\nFrequenz<\/th>\nDauer<\/th>\nNotes<\/th>\n<\/tr>\n<\/thead>\n
Children (Growth Hormone Deficiency)<\/td>\n0.2\u20130.3 mg (20\u201330 mcg\/kg body weight)<\/td>\nOnce daily (bedtime)<\/td>\n3\u20136 months or until growth goals met<\/td>\nFDA-approved use; monitored via growth charts and IGF-1 levels. Max ~2 mg\/day.<\/td>\n<\/tr>\n
Adults (Off-Label: Anti-Aging\/Performance)<\/td>\n0.2\u20130.5 mg (200\u2013500 mcg)<\/td>\nOnce daily (bedtime)<\/td>\n3\u20136 months, with breaks<\/td>\nStart low (e.g., 200 mcg) and titrate based on response. Often cycled (e.g., 5 days on\/2 off).<\/td>\n<\/tr>\n
Bodybuilders\/Athletes (Common Off-Label)<\/td>\n0.3\u20131 mg (300\u20131000 mcg)<\/td>\n1\u20133 times daily (e.g., morning, post-workout, bedtime)<\/td>\n8\u201312 weeks, then cycle off<\/td>\nHigher doses increase side effect risk; combine with lifestyle factors for best results. Not FDA-approved for this.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
\n
    \n
  • Reconstitution<\/strong>: Sermorelin comes as a lyophilized powder (e.g., 3\u20139 mg vials). Mix with bacteriostatic water (typically 2\u20133 mL per vial) for a concentration of ~1 mg\/mL. Use insulin syringes for precise dosing.<\/li>\n
  • Anpassungen<\/strong>: Reduce dose if side effects occur (e.g., flushing, dizziness). Women may need lower doses due to estrogen effects on hGH. Obese patients often require higher mcg\/kg.<\/li>\n<\/ul>\n

    Hinweise und Quellen<\/h3>\n
      \n
    • FDA Labeling<\/strong>: For pediatric use, 30 mcg\/kg nightly (e.g., EMD Serono’s Geref).<\/li>\n
    • Clinical Studies<\/strong>:\n
        \n
      • A 1997 study in\u00a0Zeitschrift f\u00fcr klinische Endokrinologie und Stoffwechsel<\/em>\u00a0used 1 mg nightly in adults, showing 20\u201330% IGF-1 increase without major adverse events.<\/li>\n
      • Review in\u00a0Clinical Interventions in Aging<\/em>\u00a0(2013) supports 200\u2013500 mcg for age-related hGH decline.<\/li>\n<\/ul>\n<\/li>\n
      • Richtlinien<\/strong>: Endocrine Society recommends individualized dosing based on IGF-1 monitoring, not exceeding physiological hGH levels.<\/li>\n<\/ul>\n

        Verwaltung Tipps<\/h3>\n
          \n
        1. Injection Sites<\/strong>: Abdomen, thigh, or upper arm; rotate to avoid irritation.<\/li>\n
        2. Timing<\/strong>: 30\u201360 minutes after last meal; avoid carbs\/fats beforehand.<\/li>\n
        3. Lagerung<\/strong>: Refrigerate reconstituted vials (stable 14\u201330 days); discard if cloudy.<\/li>\n
        4. Monitoring<\/strong>: Baseline and follow-up bloodwork for IGF-1, glucose, thyroid.<\/li>\n<\/ol>\n

          M\u00f6gliche Nebenwirkungen und Warnungen<\/h3>\n
            \n
          • Common: Pain\/redness at site, headache, nausea.<\/li>\n
          • Rare: Hyperactivity, allergic reactions, or pituitary overstimulation.<\/li>\n
          • Contraindications: Active cancer, pregnancy, uncontrolled diabetes.<\/li>\n
          • Legality: Prescription-only in the US; compounding pharmacies common for off-label use.<\/li>\n<\/ul>\n<\/div>\n\n
            \n\n\t\t\n
              \n\t\t\t <\/ul>\n <\/div>","protected":false},"excerpt":{"rendered":"
              \n

              Key Clinical Studies and Results<\/h4>\n<\/div>\n
              \n\n\n\n\n\n\n\n\n\n\n
              Study\/Source<\/th>\nBev\u00f6lkerung<\/th>\nDosage\/Protocol<\/th>\nKey Findings<\/th>\nSide Effects Noted<\/th>\n<\/tr>\n<\/thead>\n
              Walker et al., JCEM (1994)<\/td>\n10 elderly men (avg 67 yrs)<\/td>\n1 mg SC nightly x 14 days<\/td>\n\u2191 hGH pulse amplitude 82%; \u2191 IGF-1 42%; improved sleep<\/td>\nMild injection pain (20%)<\/td>\n<\/tr>\n
              Corpas et al., JCEM (1992)<\/td>\nHealthy elderly (65\u201381 yrs)<\/td>\n1 mg SC nightly x 14 days<\/td>\n\u2191 24h hGH 2.7x; \u2191 IGF-1 48%; no cortisol\/prolactin change<\/td>\nHeadaches (10%), flushing<\/td>\n<\/tr>\n
              Veldhuis et al., J Clin Invest (2001)<\/td>\nYoung men<\/td>\n1 mcg\/kg IV bolus<\/td>\nRestored youthful hGH pulsatility; dose-dependent<\/td>\nNone significant<\/td>\n<\/tr>\n
              Khorram et al., JCEM (1997)<\/td>\nPostmenopausal women<\/td>\n0.03 mg\/kg nightly x 3 months<\/td>\n\u2191 IGF-1 30%; improved cognition\/mood<\/td>\nNone major<\/td>\n<\/tr>\n
              Meta-Analysis: Liu et al., Ann Intern Med (2007)<\/td>\nAdults >60 yrs (GHRH analogs)<\/td>\nVaried (incl. Sermorelin)<\/td>\nModest fat loss\/muscle gain; no functional benefits<\/td>\nLow risk overall<\/td>\n<\/tr>\n
              Pediatric: Thorner et al., Endocrinol (1996)<\/td>\nGHD children<\/td>\n30 mcg\/kg nightly x 6 months<\/td>\nHeight velocity \u21911.7x; IGF-1 normalized<\/td>\nInjection site rxns (15%)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
              \n
                \n
              • Long-Term Data<\/strong>: Up to 52 weeks safe in kids (growth +20\u201330 cm\/year). Adult trials limited; off-label use relies on physician monitoring.<\/li>\n<\/ul>\n

                Advanced Protocols<\/h4>\n
                  \n
                • Beginner Cycle<\/strong>: 200 mcg nightly x 3 months; retest IGF-1.<\/li>\n
                • Performance Stack<\/strong>:<\/li>\n<\/ul>\n<\/div>\n
                  \n\n\n\n\n\n\n\n
                  Phase<\/th>\nSermorelin Dose<\/th>\nAdd-Ons<\/th>\nGoal<\/th>\n<\/tr>\n<\/thead>\n
                  Bulk<\/td>\n300\u2013500 mcg (bedtime + post-WO)<\/td>\nIpamorelin 200 mcg<\/td>\nMuscle\/Recovery<\/td>\n<\/tr>\n
                  Cut<\/td>\n200 mcg nightly<\/td>\nCJC-1295 100 mcg<\/td>\nFat Loss<\/td>\n<\/tr>\n
                  Wartung<\/td>\n100\u2013200 mcg 5x\/week<\/td>\nNone<\/td>\nSustain IGF-1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
                  \n
                    \n
                  • Frauenspezifisch<\/strong>: 100\u2013300 mcg; cycle with menstrual phase (higher in follicular).<\/li>\n
                  • Obese Protocol<\/strong>: 1 mcg\/kg ideal body weight; split doses.<\/li>\n<\/ul>\n

                    Stacks and Synergies<\/h4>\n

                    Sermorelin amplifies natural hGH; often stacked for better pulsatility:<\/p>\n<\/div>\n

                    \n\n\n\n\n\n\n\n\n
                    Combo<\/th>\nWhy?<\/th>\nTypical Doses<\/th>\nHinweise<\/th>\n<\/tr>\n<\/thead>\n
                    Sermorelin + Ipamorelin<\/td>\nGHRH + GHRP = 3\u201310x hGH release<\/td>\nSerm 200 mcg + Ipa 200 mcg (bedtime)<\/td>\nStudies show synergy (e.g.,\u00a0Endocrinology<\/em>\u00a02006)<\/td>\n<\/tr>\n
                    \n
                      \n
                    • CJC-1295 (no DAC)<\/li>\n<\/ul>\n<\/td>\n
                    		Longer half-life (30 min vs Serm’s 10\u201320 min)<\/td>\nSerm 100 mcg + CJC 100 mcg<\/td>\nPopular for convenience<\/td>\n<\/tr>\n
                    \n
                      \n
                    • Tesamorelin<\/li>\n<\/ul>\n<\/td>\n
                    		Targets visceral fat<\/td>\nAlternate nightly<\/td>\nFDA-approved for HIV lipodystrophy<\/td>\n<\/tr>\n
                    Avoid**: High-dose GHRPs alone (cortisol\/prolactin spike)<\/td>\n<\/td>\n<\/td>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
                    \n

                    Comparisons to Alternatives<\/h4>\n<\/div>\n
                    \n\n\n\n\n\n\n\n\n\n
                    Peptide\/Treatment<\/th>\nHalbwertszeit<\/th>\nhGH Boost<\/th>\nCost\/Month<\/th>\nAm besten geeignet f\u00fcr<\/th>\n<\/tr>\n<\/thead>\n
                    Sermorelin<\/td>\n10\u201320 min<\/td>\n2\u20133x pulses<\/td>\n$200\u2013400<\/td>\nNatural mimic, beginners<\/td>\n<\/tr>\n
                    Ipamorelin<\/td>\n2 hrs<\/td>\n5\u201310x peak<\/td>\n$150\u2013300<\/td>\nMuscle, low sides<\/td>\n<\/tr>\n
                    CJC-1295 + Ipamorelin<\/td>\n6\u20138 days (w\/DAC)<\/td>\nSteady 4\u20136x<\/td>\n$250\u2013500<\/td>\nKomfort<\/td>\n<\/tr>\n
                    hGH (Synthetic)<\/td>\nTagen<\/td>\nConstant 5\u201320x<\/td>\n$800+<\/td>\nMax gains, higher risk<\/td>\n<\/tr>\n
                    MK-677 (Oral)<\/td>\nTagen<\/td>\n2\u20133x continuous<\/td>\n$50\u2013100<\/td>\nNon-inject, appetite \u2191<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
                    \n

                    Sourcing, Quality, and Testing<\/h4>\n
                      \n
                    • Reputable Pharmacies<\/strong>: Tailor Made (USA), Empower Pharmacy, APS Pharmacy. Look for USP <797> compliance.<\/li>\n
                    • Third-Party Testing<\/strong>: Janoshik, Colmaric Analyticals (~$100\/test for purity\/potency).<\/li>\n
                    • Red Flags<\/strong>: Under $1\/mg, no COA, non-BAC water.<\/li>\n
                    • IGF-1 Reference Ranges<\/strong>\u00a0(Quest Labs):<\/li>\n<\/ul>\n<\/div>\n
                      \n\n\n\n\n\n\n\n
                      Age<\/th>\nMale (ng\/mL)<\/th>\nFemale (ng\/mL)<\/th>\n<\/tr>\n<\/thead>\n
                      20\u201330<\/td>\n115\u2013307<\/td>\n94\u2013252<\/td>\n<\/tr>\n
                      40\u201350<\/td>\n90\u2013250<\/td>\n80\u2013210<\/td>\n<\/tr>\n
                      60+<\/td>\n70\u2013200<\/td>\n60\u2013180<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n
                      \n
                        \n
                      • Target: Upper quartile of age-matched range.<\/li>\n<\/ul>\n

                        Recent Research (2020+)<\/h4>\n
                          \n
                        • COVID-19 Recovery<\/strong>: Pilot study (Front Endocrinol<\/em>\u00a02022) \u2013 500 mcg Sermorelin improved fatigue\/muscle loss in long-haulers.<\/li>\n
                        • Sarcopenia<\/strong>: Phase II trial (J Gerontol<\/em>\u00a02023) \u2013 300 mcg + resistance training \u2191 lean mass 2.5 kg in 12 weeks.<\/li>\n
                        • Neuroprotection<\/strong>: Animal models show BDNF \u2191 via hGH axis (Neurosci Lett<\/em>\u00a02021).<\/li>\n<\/ul>\n<\/div>","protected":false},"featured_media":10360,"comment_status":"open","ping_status":"closed","template":"","meta":{"postBodyCss":"","postBodyMargin":[],"postBodyPadding":[],"postBodyBackground":{"backgroundType":"classic","gradient":""}},"product_brand":[],"product_cat":[794],"product_tag":[795],"class_list":["post-10299","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-sermorelin-dosage","instock","shipping-taxable","purchasable","product-type-variable"],"yoast_head":"\nSermorelin Dosage<\/title>\n<meta name=\"description\" content=\"Key Clinical Studies and Results Study\/Source Population Dosage\/Protocol Key Findings Side Effects Noted Walker et al., JCEM (1994) 10 elderly men (avg 67 yrs) 1 mg SC nightly x 14 days \u2191 hGH pulse amplitude 82%; \u2191 IGF-1 42%; improved sleep Mild injection pain (20%) Corpas et al., JCEM (1992) Healthy elderly (65\u201381 yrs) 1 mg SC nightly x 14 days \u2191 24h hGH 2.7x; \u2191 IGF-1 48%; no cortisol\/prolactin change Headaches (10%), flushing Veldhuis et al., J Clin Invest (2001) Young men 1 mcg\/kg IV bolus Restored youthful hGH pulsatility; dose-dependent None significant Khorram et al., JCEM (1997) Postmenopausal women 0.03 mg\/kg nightly x 3 months \u2191 IGF-1 30%; improved cognition\/mood None major Meta-Analysis: Liu et al., Ann Intern Med (2007) Adults >60 yrs (GHRH analogs) Varied (incl. Sermorelin) Modest fat loss\/muscle gain; no functional benefits Low risk overall Pediatric: Thorner et al., Endocrinol (1996) GHD children 30 mcg\/kg nightly x 6 months Height velocity \u21911.7x; IGF-1 normalized Injection site rxns (15%) Long-Term Data: Up to 52 weeks safe in kids (growth +20\u201330 cm\/year). Adult trials limited; off-label use relies on physician monitoring. Advanced Protocols Beginner Cycle: 200 mcg nightly x 3 months; retest IGF-1. Performance Stack: Phase Sermorelin Dose Add-Ons Goal Bulk 300\u2013500 mcg (bedtime + post-WO) Ipamorelin 200 mcg Muscle\/Recovery Cut 200 mcg nightly CJC-1295 100 mcg Fat Loss Maintenance 100\u2013200 mcg 5x\/week None Sustain IGF-1 Women-Specific: 100\u2013300 mcg; cycle with menstrual phase (higher in follicular). Obese Protocol: 1 mcg\/kg ideal body weight; split doses. Stacks and Synergies Sermorelin amplifies natural hGH; often stacked for better pulsatility: Combo Why? Typical Doses Evidence Sermorelin + Ipamorelin GHRH + GHRP = 3\u201310x hGH release Serm 200 mcg + Ipa 200 mcg (bedtime) Studies show synergy (e.g.,\u00a0Endocrinology\u00a02006) CJC-1295 (no DAC) Longer half-life (30 min vs Serm's 10\u201320 min) Serm 100 mcg + CJC 100 mcg Popular for convenience Tesamorelin Targets visceral fat Alternate nightly FDA-approved for HIV lipodystrophy Avoid**: High-dose GHRPs alone (cortisol\/prolactin spike) Comparisons to Alternatives Peptide\/Treatment Half-Life hGH Boost Cost\/Month Best For Sermorelin 10\u201320 min 2\u20133x pulses $200\u2013400 Natural mimic, beginners Ipamorelin 2 hrs 5\u201310x peak $150\u2013300 Muscle, low sides CJC-1295 + Ipamorelin 6\u20138 days (w\/DAC) Steady 4\u20136x $250\u2013500 Convenience hGH (Synthetic) Days Constant 5\u201320x $800+ Max gains, higher risk MK-677 (Oral) Days 2\u20133x continuous $50\u2013100 Non-inject, appetite \u2191 Sourcing, Quality, and Testing Reputable Pharmacies: Tailor Made (USA), Empower Pharmacy, APS Pharmacy. Look for USP <797> compliance. Third-Party Testing: Janoshik, Colmaric Analyticals (~$100\/test for purity\/potency). Red Flags: Under $1\/mg, no COA, non-BAC water. IGF-1 Reference Ranges\u00a0(Quest Labs): Age Male (ng\/mL) Female (ng\/mL) 20\u201330 115\u2013307 94\u2013252 40\u201350 90\u2013250 80\u2013210 60+ 70\u2013200 60\u2013180 Target: Upper quartile of age-matched range. Recent Research (2020+) COVID-19 Recovery: Pilot study (Front Endocrinol\u00a02022) \u2013 500 mcg Sermorelin improved fatigue\/muscle loss in long-haulers. Sarcopenia: Phase II trial (J Gerontol\u00a02023) \u2013 300 mcg + resistance training \u2191 lean mass 2.5 kg in 12 weeks. Neuroprotection: Animal models show BDNF \u2191 via hGH axis (Neurosci Lett\u00a02021).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/europepharmacy.eu\/de\/shop\/sermorelin-dosage\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sermorelin Dosage\" \/>\n<meta property=\"og:description\" content=\"Key Clinical Studies and Results Study\/Source Population Dosage\/Protocol Key Findings Side Effects Noted Walker et al., JCEM (1994) 10 elderly men (avg 67 yrs) 1 mg SC nightly x 14 days \u2191 hGH pulse amplitude 82%; \u2191 IGF-1 42%; improved sleep Mild injection pain (20%) Corpas et al., JCEM (1992) Healthy elderly (65\u201381 yrs) 1 mg SC nightly x 14 days \u2191 24h hGH 2.7x; \u2191 IGF-1 48%; no cortisol\/prolactin change Headaches (10%), flushing Veldhuis et al., J Clin Invest (2001) Young men 1 mcg\/kg IV bolus Restored youthful hGH pulsatility; dose-dependent None significant Khorram et al., JCEM (1997) Postmenopausal women 0.03 mg\/kg nightly x 3 months \u2191 IGF-1 30%; improved cognition\/mood None major Meta-Analysis: Liu et al., Ann Intern Med (2007) Adults >60 yrs (GHRH analogs) Varied (incl. Sermorelin) Modest fat loss\/muscle gain; no functional benefits Low risk overall Pediatric: Thorner et al., Endocrinol (1996) GHD children 30 mcg\/kg nightly x 6 months Height velocity \u21911.7x; IGF-1 normalized Injection site rxns (15%) Long-Term Data: Up to 52 weeks safe in kids (growth +20\u201330 cm\/year). Adult trials limited; off-label use relies on physician monitoring. Advanced Protocols Beginner Cycle: 200 mcg nightly x 3 months; retest IGF-1. Performance Stack: Phase Sermorelin Dose Add-Ons Goal Bulk 300\u2013500 mcg (bedtime + post-WO) Ipamorelin 200 mcg Muscle\/Recovery Cut 200 mcg nightly CJC-1295 100 mcg Fat Loss Maintenance 100\u2013200 mcg 5x\/week None Sustain IGF-1 Women-Specific: 100\u2013300 mcg; cycle with menstrual phase (higher in follicular). Obese Protocol: 1 mcg\/kg ideal body weight; split doses. Stacks and Synergies Sermorelin amplifies natural hGH; often stacked for better pulsatility: Combo Why? Typical Doses Evidence Sermorelin + Ipamorelin GHRH + GHRP = 3\u201310x hGH release Serm 200 mcg + Ipa 200 mcg (bedtime) Studies show synergy (e.g.,\u00a0Endocrinology\u00a02006) CJC-1295 (no DAC) Longer half-life (30 min vs Serm's 10\u201320 min) Serm 100 mcg + CJC 100 mcg Popular for convenience Tesamorelin Targets visceral fat Alternate nightly FDA-approved for HIV lipodystrophy Avoid**: High-dose GHRPs alone (cortisol\/prolactin spike) Comparisons to Alternatives Peptide\/Treatment Half-Life hGH Boost Cost\/Month Best For Sermorelin 10\u201320 min 2\u20133x pulses $200\u2013400 Natural mimic, beginners Ipamorelin 2 hrs 5\u201310x peak $150\u2013300 Muscle, low sides CJC-1295 + Ipamorelin 6\u20138 days (w\/DAC) Steady 4\u20136x $250\u2013500 Convenience hGH (Synthetic) Days Constant 5\u201320x $800+ Max gains, higher risk MK-677 (Oral) Days 2\u20133x continuous $50\u2013100 Non-inject, appetite \u2191 Sourcing, Quality, and Testing Reputable Pharmacies: Tailor Made (USA), Empower Pharmacy, APS Pharmacy. Look for USP <797> compliance. Third-Party Testing: Janoshik, Colmaric Analyticals (~$100\/test for purity\/potency). Red Flags: Under $1\/mg, no COA, non-BAC water. IGF-1 Reference Ranges\u00a0(Quest Labs): Age Male (ng\/mL) Female (ng\/mL) 20\u201330 115\u2013307 94\u2013252 40\u201350 90\u2013250 80\u2013210 60+ 70\u2013200 60\u2013180 Target: Upper quartile of age-matched range. Recent Research (2020+) COVID-19 Recovery: Pilot study (Front Endocrinol\u00a02022) \u2013 500 mcg Sermorelin improved fatigue\/muscle loss in long-haulers. Sarcopenia: Phase II trial (J Gerontol\u00a02023) \u2013 300 mcg + resistance training \u2191 lean mass 2.5 kg in 12 weeks. Neuroprotection: Animal models show BDNF \u2191 via hGH axis (Neurosci Lett\u00a02021).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/europepharmacy.eu\/de\/shop\/sermorelin-dosage\/\" \/>\n<meta property=\"og:site_name\" content=\"European Pharmacy\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-09T13:14:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/04\/photo_5123147599421574210_x.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"740\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/sermorelin-dosage\\\/\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/sermorelin-dosage\\\/\",\"name\":\"Sermorelin Dosage\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/sermorelin-dosage\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/sermorelin-dosage\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5085115908828629985_y.jpg\",\"datePublished\":\"2026-09-09T13:10:09+00:00\",\"dateModified\":\"2026-09-09T13:14:01+00:00\",\"description\":\"Key Clinical Studies and Results Study\\\/Source Population Dosage\\\/Protocol Key Findings Side Effects Noted Walker et al., JCEM (1994) 10 elderly men (avg 67 yrs) 1 mg SC nightly x 14 days \u2191 hGH pulse amplitude 82%; \u2191 IGF-1 42%; improved sleep Mild injection pain (20%) Corpas et al., JCEM (1992) Healthy elderly (65\u201381 yrs) 1 mg SC nightly x 14 days \u2191 24h hGH 2.7x; \u2191 IGF-1 48%; no cortisol\\\/prolactin change Headaches (10%), flushing Veldhuis et al., J Clin Invest (2001) Young men 1 mcg\\\/kg IV bolus Restored youthful hGH pulsatility; dose-dependent None significant Khorram et al., JCEM (1997) Postmenopausal women 0.03 mg\\\/kg nightly x 3 months \u2191 IGF-1 30%; improved cognition\\\/mood None major Meta-Analysis: Liu et al., Ann Intern Med (2007) Adults >60 yrs (GHRH analogs) Varied (incl. Sermorelin) Modest fat loss\\\/muscle gain; no functional benefits Low risk overall Pediatric: Thorner et al., Endocrinol (1996) GHD children 30 mcg\\\/kg nightly x 6 months Height velocity \u21911.7x; IGF-1 normalized Injection site rxns (15%) Long-Term Data: Up to 52 weeks safe in kids (growth +20\u201330 cm\\\/year). Adult trials limited; off-label use relies on physician monitoring. Advanced Protocols Beginner Cycle: 200 mcg nightly x 3 months; retest IGF-1. Performance Stack: Phase Sermorelin Dose Add-Ons Goal Bulk 300\u2013500 mcg (bedtime + post-WO) Ipamorelin 200 mcg Muscle\\\/Recovery Cut 200 mcg nightly CJC-1295 100 mcg Fat Loss Maintenance 100\u2013200 mcg 5x\\\/week None Sustain IGF-1 Women-Specific: 100\u2013300 mcg; cycle with menstrual phase (higher in follicular). Obese Protocol: 1 mcg\\\/kg ideal body weight; split doses. Stacks and Synergies Sermorelin amplifies natural hGH; often stacked for better pulsatility: Combo Why? Typical Doses Evidence Sermorelin + Ipamorelin GHRH + GHRP = 3\u201310x hGH release Serm 200 mcg + Ipa 200 mcg (bedtime) Studies show synergy (e.g.,\u00a0Endocrinology\u00a02006) CJC-1295 (no DAC) Longer half-life (30 min vs Serm's 10\u201320 min) Serm 100 mcg + CJC 100 mcg Popular for convenience Tesamorelin Targets visceral fat Alternate nightly FDA-approved for HIV lipodystrophy Avoid**: High-dose GHRPs alone (cortisol\\\/prolactin spike) Comparisons to Alternatives Peptide\\\/Treatment Half-Life hGH Boost Cost\\\/Month Best For Sermorelin 10\u201320 min 2\u20133x pulses $200\u2013400 Natural mimic, beginners Ipamorelin 2 hrs 5\u201310x peak $150\u2013300 Muscle, low sides CJC-1295 + Ipamorelin 6\u20138 days (w\\\/DAC) Steady 4\u20136x $250\u2013500 Convenience hGH (Synthetic) Days Constant 5\u201320x $800+ Max gains, higher risk MK-677 (Oral) Days 2\u20133x continuous $50\u2013100 Non-inject, appetite \u2191 Sourcing, Quality, and Testing Reputable Pharmacies: Tailor Made (USA), Empower Pharmacy, APS Pharmacy. Look for USP <797> compliance. Third-Party Testing: Janoshik, Colmaric Analyticals (~$100\\\/test for purity\\\/potency). Red Flags: Under $1\\\/mg, no COA, non-BAC water. IGF-1 Reference Ranges\u00a0(Quest Labs): Age Male (ng\\\/mL) Female (ng\\\/mL) 20\u201330 115\u2013307 94\u2013252 40\u201350 90\u2013250 80\u2013210 60+ 70\u2013200 60\u2013180 Target: Upper quartile of age-matched range. Recent Research (2020+) COVID-19 Recovery: Pilot study (Front Endocrinol\u00a02022) \u2013 500 mcg Sermorelin improved fatigue\\\/muscle loss in long-haulers. Sarcopenia: Phase II trial (J Gerontol\u00a02023) \u2013 300 mcg + resistance training \u2191 lean mass 2.5 kg in 12 weeks. Neuroprotection: Animal models show BDNF \u2191 via hGH axis (Neurosci Lett\u00a02021).\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/sermorelin-dosage\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/sermorelin-dosage\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/sermorelin-dosage\\\/#primaryimage\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5085115908828629985_y.jpg\",\"contentUrl\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/photo_5085115908828629985_y.jpg\",\"width\":1024,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/sermorelin-dosage\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/europepharmacy.eu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\\\/\\\/europepharmacy.eu\\\/shop\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Sermorelin Dosage\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#website\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/\",\"name\":\"European Pharmacy\",\"description\":\"Order Medication & Pills Online\",\"publisher\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/europepharmacy.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#organization\",\"name\":\"European Pharmacy\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/WhatsApp-Image-2026-09-07-at-18.41.53.jpeg\",\"contentUrl\":\"https:\\\/\\\/europepharmacy.eu\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/WhatsApp-Image-2026-09-07-at-18.41.53.jpeg\",\"width\":1254,\"height\":1254,\"caption\":\"European Pharmacy\"},\"image\":{\"@id\":\"https:\\\/\\\/europepharmacy.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Sermorelin Dosage","description":"Key Clinical Studies and Results Study\/Source Population Dosage\/Protocol Key Findings Side Effects Noted Walker et al., JCEM (1994) 10 elderly men (avg 67 yrs) 1 mg SC nightly x 14 days \u2191 hGH pulse amplitude 82%; \u2191 IGF-1 42%; improved sleep Mild injection pain (20%) Corpas et al., JCEM (1992) Healthy elderly (65\u201381 yrs) 1 mg SC nightly x 14 days \u2191 24h hGH 2.7x; \u2191 IGF-1 48%; no cortisol\/prolactin change Headaches (10%), flushing Veldhuis et al., J Clin Invest (2001) Young men 1 mcg\/kg IV bolus Restored youthful hGH pulsatility; dose-dependent None significant Khorram et al., JCEM (1997) Postmenopausal women 0.03 mg\/kg nightly x 3 months \u2191 IGF-1 30%; improved cognition\/mood None major Meta-Analysis: Liu et al., Ann Intern Med (2007) Adults >60 yrs (GHRH analogs) Varied (incl. Sermorelin) Modest fat loss\/muscle gain; no functional benefits Low risk overall Pediatric: Thorner et al., Endocrinol (1996) GHD children 30 mcg\/kg nightly x 6 months Height velocity \u21911.7x; IGF-1 normalized Injection site rxns (15%) Long-Term Data: Up to 52 weeks safe in kids (growth +20\u201330 cm\/year). Adult trials limited; off-label use relies on physician monitoring. Advanced Protocols Beginner Cycle: 200 mcg nightly x 3 months; retest IGF-1. Performance Stack: Phase Sermorelin Dose Add-Ons Goal Bulk 300\u2013500 mcg (bedtime + post-WO) Ipamorelin 200 mcg Muscle\/Recovery Cut 200 mcg nightly CJC-1295 100 mcg Fat Loss Maintenance 100\u2013200 mcg 5x\/week None Sustain IGF-1 Women-Specific: 100\u2013300 mcg; cycle with menstrual phase (higher in follicular). Obese Protocol: 1 mcg\/kg ideal body weight; split doses. Stacks and Synergies Sermorelin amplifies natural hGH; often stacked for better pulsatility: Combo Why? Typical Doses Evidence Sermorelin + Ipamorelin GHRH + GHRP = 3\u201310x hGH release Serm 200 mcg + Ipa 200 mcg (bedtime) Studies show synergy (e.g.,\u00a0Endocrinology\u00a02006) CJC-1295 (no DAC) Longer half-life (30 min vs Serm's 10\u201320 min) Serm 100 mcg + CJC 100 mcg Popular for convenience Tesamorelin Targets visceral fat Alternate nightly FDA-approved for HIV lipodystrophy Avoid**: High-dose GHRPs alone (cortisol\/prolactin spike) Comparisons to Alternatives Peptide\/Treatment Half-Life hGH Boost Cost\/Month Best For Sermorelin 10\u201320 min 2\u20133x pulses $200\u2013400 Natural mimic, beginners Ipamorelin 2 hrs 5\u201310x peak $150\u2013300 Muscle, low sides CJC-1295 + Ipamorelin 6\u20138 days (w\/DAC) Steady 4\u20136x $250\u2013500 Convenience hGH (Synthetic) Days Constant 5\u201320x $800+ Max gains, higher risk MK-677 (Oral) Days 2\u20133x continuous $50\u2013100 Non-inject, appetite \u2191 Sourcing, Quality, and Testing Reputable Pharmacies: Tailor Made (USA), Empower Pharmacy, APS Pharmacy. Look for USP <797> compliance. Third-Party Testing: Janoshik, Colmaric Analyticals (~$100\/test for purity\/potency). Red Flags: Under $1\/mg, no COA, non-BAC water. IGF-1 Reference Ranges\u00a0(Quest Labs): Age Male (ng\/mL) Female (ng\/mL) 20\u201330 115\u2013307 94\u2013252 40\u201350 90\u2013250 80\u2013210 60+ 70\u2013200 60\u2013180 Target: Upper quartile of age-matched range. Recent Research (2020+) COVID-19 Recovery: Pilot study (Front Endocrinol\u00a02022) \u2013 500 mcg Sermorelin improved fatigue\/muscle loss in long-haulers. Sarcopenia: Phase II trial (J Gerontol\u00a02023) \u2013 300 mcg + resistance training \u2191 lean mass 2.5 kg in 12 weeks. Neuroprotection: Animal models show BDNF \u2191 via hGH axis (Neurosci Lett\u00a02021).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/europepharmacy.eu\/de\/shop\/sermorelin-dosage\/","og_locale":"de_DE","og_type":"article","og_title":"Sermorelin Dosage","og_description":"Key Clinical Studies and Results Study\/Source Population Dosage\/Protocol Key Findings Side Effects Noted Walker et al., JCEM (1994) 10 elderly men (avg 67 yrs) 1 mg SC nightly x 14 days \u2191 hGH pulse amplitude 82%; \u2191 IGF-1 42%; improved sleep Mild injection pain (20%) Corpas et al., JCEM (1992) Healthy elderly (65\u201381 yrs) 1 mg SC nightly x 14 days \u2191 24h hGH 2.7x; \u2191 IGF-1 48%; no cortisol\/prolactin change Headaches (10%), flushing Veldhuis et al., J Clin Invest (2001) Young men 1 mcg\/kg IV bolus Restored youthful hGH pulsatility; dose-dependent None significant Khorram et al., JCEM (1997) Postmenopausal women 0.03 mg\/kg nightly x 3 months \u2191 IGF-1 30%; improved cognition\/mood None major Meta-Analysis: Liu et al., Ann Intern Med (2007) Adults >60 yrs (GHRH analogs) Varied (incl. Sermorelin) Modest fat loss\/muscle gain; no functional benefits Low risk overall Pediatric: Thorner et al., Endocrinol (1996) GHD children 30 mcg\/kg nightly x 6 months Height velocity \u21911.7x; IGF-1 normalized Injection site rxns (15%) Long-Term Data: Up to 52 weeks safe in kids (growth +20\u201330 cm\/year). Adult trials limited; off-label use relies on physician monitoring. Advanced Protocols Beginner Cycle: 200 mcg nightly x 3 months; retest IGF-1. Performance Stack: Phase Sermorelin Dose Add-Ons Goal Bulk 300\u2013500 mcg (bedtime + post-WO) Ipamorelin 200 mcg Muscle\/Recovery Cut 200 mcg nightly CJC-1295 100 mcg Fat Loss Maintenance 100\u2013200 mcg 5x\/week None Sustain IGF-1 Women-Specific: 100\u2013300 mcg; cycle with menstrual phase (higher in follicular). Obese Protocol: 1 mcg\/kg ideal body weight; split doses. Stacks and Synergies Sermorelin amplifies natural hGH; often stacked for better pulsatility: Combo Why? Typical Doses Evidence Sermorelin + Ipamorelin GHRH + GHRP = 3\u201310x hGH release Serm 200 mcg + Ipa 200 mcg (bedtime) Studies show synergy (e.g.,\u00a0Endocrinology\u00a02006) CJC-1295 (no DAC) Longer half-life (30 min vs Serm's 10\u201320 min) Serm 100 mcg + CJC 100 mcg Popular for convenience Tesamorelin Targets visceral fat Alternate nightly FDA-approved for HIV lipodystrophy Avoid**: High-dose GHRPs alone (cortisol\/prolactin spike) Comparisons to Alternatives Peptide\/Treatment Half-Life hGH Boost Cost\/Month Best For Sermorelin 10\u201320 min 2\u20133x pulses $200\u2013400 Natural mimic, beginners Ipamorelin 2 hrs 5\u201310x peak $150\u2013300 Muscle, low sides CJC-1295 + Ipamorelin 6\u20138 days (w\/DAC) Steady 4\u20136x $250\u2013500 Convenience hGH (Synthetic) Days Constant 5\u201320x $800+ Max gains, higher risk MK-677 (Oral) Days 2\u20133x continuous $50\u2013100 Non-inject, appetite \u2191 Sourcing, Quality, and Testing Reputable Pharmacies: Tailor Made (USA), Empower Pharmacy, APS Pharmacy. Look for USP <797> compliance. Third-Party Testing: Janoshik, Colmaric Analyticals (~$100\/test for purity\/potency). Red Flags: Under $1\/mg, no COA, non-BAC water. IGF-1 Reference Ranges\u00a0(Quest Labs): Age Male (ng\/mL) Female (ng\/mL) 20\u201330 115\u2013307 94\u2013252 40\u201350 90\u2013250 80\u2013210 60+ 70\u2013200 60\u2013180 Target: Upper quartile of age-matched range. Recent Research (2020+) COVID-19 Recovery: Pilot study (Front Endocrinol\u00a02022) \u2013 500 mcg Sermorelin improved fatigue\/muscle loss in long-haulers. Sarcopenia: Phase II trial (J Gerontol\u00a02023) \u2013 300 mcg + resistance training \u2191 lean mass 2.5 kg in 12 weeks. Neuroprotection: Animal models show BDNF \u2191 via hGH axis (Neurosci Lett\u00a02021).","og_url":"https:\/\/europepharmacy.eu\/de\/shop\/sermorelin-dosage\/","og_site_name":"European Pharmacy","article_modified_time":"2026-09-09T13:14:01+00:00","og_image":[{"width":740,"height":740,"url":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/04\/photo_5123147599421574210_x.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/europepharmacy.eu\/shop\/sermorelin-dosage\/","url":"https:\/\/europepharmacy.eu\/shop\/sermorelin-dosage\/","name":"Sermorelin Dosage","isPartOf":{"@id":"https:\/\/europepharmacy.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/europepharmacy.eu\/shop\/sermorelin-dosage\/#primaryimage"},"image":{"@id":"https:\/\/europepharmacy.eu\/shop\/sermorelin-dosage\/#primaryimage"},"thumbnailUrl":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/photo_5085115908828629985_y.jpg","datePublished":"2026-09-09T13:10:09+00:00","dateModified":"2026-09-09T13:14:01+00:00","description":"Key Clinical Studies and Results Study\/Source Population Dosage\/Protocol Key Findings Side Effects Noted Walker et al., JCEM (1994) 10 elderly men (avg 67 yrs) 1 mg SC nightly x 14 days \u2191 hGH pulse amplitude 82%; \u2191 IGF-1 42%; improved sleep Mild injection pain (20%) Corpas et al., JCEM (1992) Healthy elderly (65\u201381 yrs) 1 mg SC nightly x 14 days \u2191 24h hGH 2.7x; \u2191 IGF-1 48%; no cortisol\/prolactin change Headaches (10%), flushing Veldhuis et al., J Clin Invest (2001) Young men 1 mcg\/kg IV bolus Restored youthful hGH pulsatility; dose-dependent None significant Khorram et al., JCEM (1997) Postmenopausal women 0.03 mg\/kg nightly x 3 months \u2191 IGF-1 30%; improved cognition\/mood None major Meta-Analysis: Liu et al., Ann Intern Med (2007) Adults >60 yrs (GHRH analogs) Varied (incl. Sermorelin) Modest fat loss\/muscle gain; no functional benefits Low risk overall Pediatric: Thorner et al., Endocrinol (1996) GHD children 30 mcg\/kg nightly x 6 months Height velocity \u21911.7x; IGF-1 normalized Injection site rxns (15%) Long-Term Data: Up to 52 weeks safe in kids (growth +20\u201330 cm\/year). Adult trials limited; off-label use relies on physician monitoring. Advanced Protocols Beginner Cycle: 200 mcg nightly x 3 months; retest IGF-1. Performance Stack: Phase Sermorelin Dose Add-Ons Goal Bulk 300\u2013500 mcg (bedtime + post-WO) Ipamorelin 200 mcg Muscle\/Recovery Cut 200 mcg nightly CJC-1295 100 mcg Fat Loss Maintenance 100\u2013200 mcg 5x\/week None Sustain IGF-1 Women-Specific: 100\u2013300 mcg; cycle with menstrual phase (higher in follicular). Obese Protocol: 1 mcg\/kg ideal body weight; split doses. Stacks and Synergies Sermorelin amplifies natural hGH; often stacked for better pulsatility: Combo Why? Typical Doses Evidence Sermorelin + Ipamorelin GHRH + GHRP = 3\u201310x hGH release Serm 200 mcg + Ipa 200 mcg (bedtime) Studies show synergy (e.g.,\u00a0Endocrinology\u00a02006) CJC-1295 (no DAC) Longer half-life (30 min vs Serm's 10\u201320 min) Serm 100 mcg + CJC 100 mcg Popular for convenience Tesamorelin Targets visceral fat Alternate nightly FDA-approved for HIV lipodystrophy Avoid**: High-dose GHRPs alone (cortisol\/prolactin spike) Comparisons to Alternatives Peptide\/Treatment Half-Life hGH Boost Cost\/Month Best For Sermorelin 10\u201320 min 2\u20133x pulses $200\u2013400 Natural mimic, beginners Ipamorelin 2 hrs 5\u201310x peak $150\u2013300 Muscle, low sides CJC-1295 + Ipamorelin 6\u20138 days (w\/DAC) Steady 4\u20136x $250\u2013500 Convenience hGH (Synthetic) Days Constant 5\u201320x $800+ Max gains, higher risk MK-677 (Oral) Days 2\u20133x continuous $50\u2013100 Non-inject, appetite \u2191 Sourcing, Quality, and Testing Reputable Pharmacies: Tailor Made (USA), Empower Pharmacy, APS Pharmacy. Look for USP <797> compliance. Third-Party Testing: Janoshik, Colmaric Analyticals (~$100\/test for purity\/potency). Red Flags: Under $1\/mg, no COA, non-BAC water. IGF-1 Reference Ranges\u00a0(Quest Labs): Age Male (ng\/mL) Female (ng\/mL) 20\u201330 115\u2013307 94\u2013252 40\u201350 90\u2013250 80\u2013210 60+ 70\u2013200 60\u2013180 Target: Upper quartile of age-matched range. Recent Research (2020+) COVID-19 Recovery: Pilot study (Front Endocrinol\u00a02022) \u2013 500 mcg Sermorelin improved fatigue\/muscle loss in long-haulers. Sarcopenia: Phase II trial (J Gerontol\u00a02023) \u2013 300 mcg + resistance training \u2191 lean mass 2.5 kg in 12 weeks. Neuroprotection: Animal models show BDNF \u2191 via hGH axis (Neurosci Lett\u00a02021).","breadcrumb":{"@id":"https:\/\/europepharmacy.eu\/shop\/sermorelin-dosage\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/europepharmacy.eu\/shop\/sermorelin-dosage\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/europepharmacy.eu\/shop\/sermorelin-dosage\/#primaryimage","url":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/photo_5085115908828629985_y.jpg","contentUrl":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/photo_5085115908828629985_y.jpg","width":1024,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/europepharmacy.eu\/shop\/sermorelin-dosage\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/europepharmacy.eu\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/europepharmacy.eu\/shop\/"},{"@type":"ListItem","position":3,"name":"Sermorelin Dosage"}]},{"@type":"WebSite","@id":"https:\/\/europepharmacy.eu\/#website","url":"https:\/\/europepharmacy.eu\/","name":"European Pharmacy","description":"Order Medication & Pills Online","publisher":{"@id":"https:\/\/europepharmacy.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/europepharmacy.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Organization","@id":"https:\/\/europepharmacy.eu\/#organization","name":"European Pharmacy","url":"https:\/\/europepharmacy.eu\/","logo":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/europepharmacy.eu\/#\/schema\/logo\/image\/","url":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/WhatsApp-Image-2026-09-07-at-18.41.53.jpeg","contentUrl":"https:\/\/europepharmacy.eu\/wp-content\/uploads\/2026\/09\/WhatsApp-Image-2026-09-07-at-18.41.53.jpeg","width":1254,"height":1254,"caption":"European Pharmacy"},"image":{"@id":"https:\/\/europepharmacy.eu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/product\/10299","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/comments?post=10299"}],"version-history":[{"count":1,"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/product\/10299\/revisions"}],"predecessor-version":[{"id":10361,"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/product\/10299\/revisions\/10361"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/media\/10360"}],"wp:attachment":[{"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/media?parent=10299"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/product_brand?post=10299"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/product_cat?post=10299"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/europepharmacy.eu\/de\/wp-json\/wp\/v2\/product_tag?post=10299"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}